Evidence map›Paper›PMID 26216399›Full record

ArticleIranian biomedical journal2015

Protective Role of Oleuropein against Acute Deltamethrin-Induced Neurotoxicity in Rat Brain.

Ali Reza Khalatbary, Elmira Ghaffari, Behrooz Mohammadnegad

Open access · greenAbstract read
In one paragraph

Article in Iranian biomedical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ali Reza KhalatbaryMolecular and Cell Biology Research Center, Dept. of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Elmira GhaffariDept. of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Behrooz MohammadnegadDept. of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Mazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeltamethrin (DM) is a synthetic pyrethroid insecticide that can elicit neurotoxicity, leading to apoptosis. There is accumulating evidence that oleuropein (OE) has anti-apoptotic effect. The purpose of this study was to determine the anti-apoptotic effect of OE pretreatment in the neuronal cells of cerebral cortex.

methodsRats were randomly divided into four groups each containing five rats: DM-treated group (12.5 mg/kg, a single dose), OE-treated group (20 mg/kg per day), DM + OE-treated group, and vehicle group. Sections of the brain were obtained 24 hours after DM injection and studied for histopathological and immunohistochemistry assessment.

resultsThe histopathological assessments showed lesser characteristics of neural degeneration in DM + OE group compared with DM group. Greater Bcl-2 and attenuated Bax expression could be detected in the DM + OE treated-mice compared with DM group.

conclusionThe results suggested that DM-induced neurotoxicity can be subsided by OE.

Indexed as

AnimalsApoptosisbcl-2-Associated X ProteinCerebral CortexFemaleInsecticidesIridoid GlucosidesIridoidsNeuronsNeuroprotective AgentsNeurotoxicity SyndromesNeurotoxinsNitrilesProto-Oncogene Proteins c-bcl-2PyrethrinsRatsbcl-2-Associated X ProteindecamethrinInsecticidesIridoid GlucosidesIridoidsNeuroprotective AgentsNeurotoxinsNitrilesoleuropeinProto-Oncogene Proteins c-bcl-2PyrethrinsApoptosisDeltamethrinOleuropein

Identifiers

PMID26216399
PMCPMC4649861
OpenAlexW2186844605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.